Catalog No.
YVV33201
Expression system
E. coli
Species
Porcine parvovirus
Protein length
Gln7-Tyr579
Predicted molecular weight
107.41 kDa
Nature
Recombinant
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
D9J2H4
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Capsid protein VP2
Note
For research use only.
Induction of immune responses in mice after intragastric administration of Lactobacillus casei producing porcine parvovirus VP2 protein., PMID:17827311
[Co-expression of CSFV T cell epitope E290 peptide and PPV VP2 protein in Lactobacillus casei and determination of specific antibodies in immunized mice]., PMID:17944369
Construction of recombinant Lactobacillus casei efficiently surface displayed and secreted porcine parvovirus VP2 protein and comparison of the immune responses induced by oral immunization., PMID:18034821
Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2., PMID:18378364
Phylogeny and evolution of the NS1 and VP1/VP2 gene sequences from porcine parvovirus., PMID:19047005
Expression of porcine parvovirus VP2 gene requires codon optimized E. coli cells., PMID:19543964
Comparison of the immune responses induced by oral immunization of mice with Lactobacillus casei-expressing porcine parvovirus VP2 and VP2 fused to Escherichia coli heat-labile enterotoxin B subunit protein., PMID:20226529
[Construction and immunogenicity of recombinant porcine parvovirus-like particles with somatostatin]., PMID:21090109
Production and purification of VP2 protein of porcine parvovirus expressed in an insect-baculovirus cell system., PMID:21143963
Complete coding sequences and phylogenetic analysis of porcine bocavirus., PMID:21228124
A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine., PMID:21679423
The RNA profile of porcine parvovirus 4, a boca-like virus, is unique among the parvoviruses., PMID:21785854
High rate of viral evolution in the capsid protein of porcine parvovirus., PMID:21795474
Immunogenicity of recombinant classic swine fever virus CD8(+) T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by Lactobacillus casei in swine via oral vaccination., PMID:21940406
[Effect of the glycine-rich region deleted PPV VP2 to the VLPs]., PMID:22506413
Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of Plasmodium., PMID:22529915
Phylogeny and evolutionary genetics of porcine parvovirus in wild boars., PMID:22575819
Characterization of the capsid protein VP2 gene of a virulent strain NE/09 of porcine parvovirus isolated in China., PMID:23021153
Influence of minor displacements in loops of the porcine parvovirus VP2 capsid on virus-like particles assembly and the induction of antibody responses., PMID:23430711
Production and immunogenicity of VP2 protein of porcine parvovirus expressed in Pichia pastoris., PMID:24221249
Development and evaluation of the rVP-ELISA for detection of antibodies against porcine parvovirus., PMID:24945904
Generation of recombinant porcine parvovirus virus-like particles in Saccharomyces cerevisiae and development of virus-specific monoclonal antibodies., PMID:25045718
Classic nuclear localization signals and a novel nuclear localization motif are required for nuclear transport of porcine parvovirus capsid proteins., PMID:25078698
Identification of three PPV1 VP2 protein-specific B cell linear epitopes using monoclonal antibodies against baculovirus-expressed recombinant VP2 protein., PMID:26153140
Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease., PMID:26685093
[Immune Response of Recombinant Pseudorabies Virus rPRV-VP2 Expressing VP2 Gene of Porcine Parvovirus in Mice]., PMID:27396164
Porcine parvovirus capsid protein expressed in Escherichia coli self-assembles into virus-like particles with high immunogenicity in mice and guinea pigs., PMID:28063996
The role of nuclear localization signal in parvovirus life cycle., PMID:28410597
An exo probe-based recombinase polymerase amplification assay for the rapid detection of porcine parvovirus., PMID:28690087
Perspectives on the Evolution of Porcine Parvovirus., PMID:28933737
Enhanced Production of Recombinant Protein by Fusion Expression with Ssp DnaB Mini-Intein in the Baculovirus Expression System., PMID:30257457
Examination and Reconstruction of Three Ancient Endogenous Parvovirus Capsid Protein Gene Remnants Found in Rodent Genomes., PMID:30626673
Comparison of immune responses induced by porcine parvovirus virus-like particles and inactivated vaccine., PMID:30852473
Porcine parvovirus VP1/VP2 on a time series epitope mapping: exploring the effects of high hydrostatic pressure on the immune recognition of antigens., PMID:31159841
Molecular epidemiology of Canine parvovirus shows CPV-2a genotype circulating in dogs from western India., PMID:31377400
Characterization of a recombinant pseudorabies virus expressing porcine parvovirus VP2 protein and porcine IL-6., PMID:32014014
Large-scale manufacture of VP2 VLP vaccine against porcine parvovirus in Escherichia coli with high-density fermentation., PMID:32130468
Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2., PMID:32255758
The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus., PMID:32827923
Identification of a dominant linear epitope on the VP2 capsid protein of porcine parvovirus and characterization of two monoclonal antibodies with neutralizing abilities., PMID:32931829
Capsid assembly is regulated by amino acid residues asparagine 47 and 48 in the VP2 protein of porcine parvovirus., PMID:33433338
SYNCRIP facilitates porcine parvovirus viral DNA replication through the alternative splicing of NS1 mRNA to promote NS2 mRNA formation., PMID:34034820
Development of a rapid loop-mediated isothermal amplification (LAMP) assay for visual detection of porcine parvovirus (PPV) and its application., PMID:34241828
Viral Fitness and Antigenic Determinants of Porcine Parvovirus at the Amino Acid Level of the Capsid Protein., PMID:34757840
The first report of porcine parvovirus 7 (PPV7) in Colombia demonstrates the presence of variants associated with modifications at the level of the VP2-capsid protein., PMID:34914702
Self-Assembly of Porcine Parvovirus Virus-like Particles and Their Application in Serological Assay., PMID:36016450
Expression and self-assembly of virus-like particles from porcine parvovirus and its application in antibody detection., PMID:38088304
Chloroplast display of subunit vaccines and their efficacy via oral administration., PMID:38163512
A novel lateral flow immunochromatographic assay using a recombinant VP2 antigen for total antibody detection of canine parvovirus-2., PMID:38186287
Chimeric Porcine Parvovirus VP2 Virus-like Particles with Epitopes of South African Serotype 2 Foot-and-Mouth Disease Virus Elicits Specific Humoral and Cellular Responses in Mice., PMID:38675963
For research use only. Not for human or drug use.
